CLAUDIA SKIBA: Open Payments
NPI 1275266926 · FLORHAM PARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,227 in 44 payments from 12 companies in 2025. Trend: 2023 $621 · 2024 $568 · 2025 $1,227
Food & beverage: $1,038Education: $189
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $357 |
| Arcutis Biotherapeutics, Inc. | 7 | $213 |
| Incyte Corporation | 1 | $126 |
| Lilly USA, LLC | 1 | $125 |
| GENZYME CORPORATION | 2 | $121 |
| Janssen Biotech, Inc. | 2 | $114 |
| SANOFI-AVENTIS U.S. LLC | 1 | $90 |
| PFIZER INC. | 1 | $20 |
| LEO Pharma Inc. | 1 | $18 |
| UCB, Inc. | 1 | $16 |
Products named: SKYRIZI, Zoryve, DUPIXENT, Opzelura, EBGLYSS, TREMFYA, RINVOQ, CIBINQO.
Industry payments across NJ — which companies pay providers there.
